Michael E Hurwitz (Michael Hurwitz)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 11

Top Topics

Acute Lymphoblastic Leukemia

Top Venues

Cancer immunology, immunotherapy : CII

Cancer discovery

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Current oncology reports

This page only lists publications with an associated author ORCID identifier.

Publications

Oscar Perales, Lucia B Jilaveanu, Adebowale J Adeniran, David G Su, Michael E Hurwitz, David A Braun, Harriet M Kluger, David A Schoenfeld
TIGIT expression in renal cell carcinoma infiltrating T cells is variable and inversely correlated with PD-1 and LAG3. Cancer immunology, immunotherapy : CII 73 (10) (2024)
Sumanta Kumar Pal, Ben Tran, John B A G Haanen, Michael E Hurwitz, Adrian Sacher, Nizar M Tannir, L Elizabeth Elizabeth Budde, Simon James Harrison, Sebastian Klobuch, Sagar S Patel, Luis Meza, Mary-Lee Dequeant, Anna Ma, Qiuling Ally He, Leah M Williams, Alissa Keegan, Ellen B Gurary, Henia Dar, Sushant Karnik, Changan Guo, Heidi Heath, Rachel R Yuen, Phuong K Morrow, Archana M Agarwal, Samer A Srour
CD70-Targeted Allogeneic CAR T-Cell Therapy for Advanced Clear Cell Renal Cell Carcinoma. Cancer discovery 14 (7) (2024)
Oscar Perales, Lucia B Jilaveanu, Adebowale J Adeniran, David G Su, Michael E Hurwitz, David A Braun, Harriet M Kluger, David A Schoenfeld
TIGIT expression in renal cell carcinoma infiltrating T cells is variable and inversely correlated with PD-1 and LAG3. Cancer immunology, immunotherapy : CII 73 (10) (2024)
Oscar Perales, Lucia B Jilaveanu, Adebowale J Adeniran, David G Su, Michael E Hurwitz, David A Braun, Harriet M Kluger, David A Schoenfeld
TIGIT expression in renal cell carcinoma infiltrating T cells is variable and inversely correlated with PD-1 and LAG3. Cancer immunology, immunotherapy : CII 73 (10) (2024)
Sumanta Kumar Pal, Ben Tran, John B A G Haanen, Michael E Hurwitz, Adrian Sacher, Nizar M Tannir, L Elizabeth Elizabeth Budde, Simon James Harrison, Sebastian Klobuch, Sagar S Patel, Luis Meza, Mary-Lee Dequeant, Anna Ma, Qiuling Ally He, Leah M Williams, Alissa Keegan, Ellen B Gurary, Henia Dar, Sushant Karnik, Changan Guo, Heidi Heath, Rachel R Yuen, Phuong K Morrow, Archana M Agarwal, Samer A Srour
CD70-Targeted Allogeneic CAR T-Cell Therapy for Advanced Clear Cell Renal Cell Carcinoma. Cancer discovery 14 (7) (2024)
Sumanta Kumar Pal, Ben Tran, John B A G Haanen, Michael E Hurwitz, Adrian Sacher, Nizar M Tannir, L Elizabeth Elizabeth Budde, Simon James Harrison, Sebastian Klobuch, Sagar S Patel, Luis Meza, Mary-Lee Dequeant, Anna Ma, Qiuling Ally He, Leah M Williams, Alissa Keegan, Ellen B Gurary, Henia Dar, Sushant Karnik, Changan Guo, Heidi Heath, Rachel R Yuen, Phuong K Morrow, Archana M Agarwal, Samer A Srour
CD70-Targeted Allogeneic CAR T-Cell Therapy for Advanced Clear Cell Renal Cell Carcinoma. Cancer discovery (2024)
Sumanta Kumar Pal, Ben Tran, John B A G Haanen, Michael E Hurwitz, Adrian Sacher, Nizar M Tannir, L Elizabeth Elizabeth Budde, Simon James Harrison, Sebastian Klobuch, Sagar S Patel, Luis Meza, Mary-Lee Dequeant, Anna Ma, Qiuling Ally He, Leah M Williams, Alissa Keegan, Ellen B Gurary, Henia Dar, Sushant Karnik, Changan Guo, Heidi Heath, Rachel R Yuen, Phuong K Morrow, Archana M Agarwal, Samer A Srour
CD70-Targeted Allogeneic CAR T-Cell Therapy for Advanced Clear Cell Renal Cell Carcinoma. Cancer discovery 14 (7) (2024)
Oscar Perales, Lucia B Jilaveanu, Adebowale J Adeniran, David G Su, Michael E Hurwitz, David A Braun, Harriet M Kluger, David A Schoenfeld
TIGIT expression in renal cell carcinoma infiltrating T cells is variable and inversely correlated with PD-1 and LAG3. Cancer immunology, immunotherapy : CII 73 (10) (2024)
Michael B Atkins, Opeyemi A Jagede, Naomi B Haas, David F McDermott, Mehmet A Bilen, Mark N Stein, Jeffrey A Sosman, Robert Alter, Elizabeth R Plimack, Moshe C Ornstein, Michael E Hurwitz, David J Peace, Sabina Signoretti, Thomas Denize, Alessia Cimadamore, Catherine J Wu, David A Braun, David J Einstein, Paul J Catalano, Hans Hammers
Phase II Study of Nivolumab and Salvage Nivolumab/Ipilimumab in Treatment-Naive Patients With Advanced Clear Cell Renal Cell Carcinoma (HCRN GU16-260-Cohort A). Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (25) (2022)
Bryden Considine, Adebowale Adeniran, Michael E Hurwitz
Current Understanding and Management of Intraductal Carcinoma of the Prostate. Current oncology reports 23 (9) (2021)
Adi Diab, Scott S Tykodi, Gregory A Daniels, Michele Maio, Brendan D Curti, Karl D Lewis, Sekwon Jang, Ewa Anna Kalinka, Igor Puzanov, Alexander I Spira, Daniel C Cho, Shanhong Guan, Erika G Puente, Tuan Nguyen, Ute Hoch, Sue L Currie, Wei Lin, Mary A Tagliaferri, Jonathan Zalevsky, Mario Sznol, Michael E Hurwitz
Bempegaldesleukin Plus Nivolumab in First-Line Metastatic Melanoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (26) (2021)